Frontlight ResearchEarly access
Trial site
Hospital El Cruce
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)2 trials
- Amyloidosis1 trial
- Coronary artery disease1 trial
- Liver cirrhosis1 trial
- Primary biliary cholangitis1 trial
- Phase
- Phase 37 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Completed2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim2 trials
- Ipsen2 trials
- Intellia Therapeutics1 trial
- Ionis Pharmaceuticals, Inc.1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Liver cirrhosis1 recruiting
- Primary biliary cholangitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026